カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のポナチニブ薬物市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Ponatinib Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19557）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19557
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：70
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のポナチニブ薬物市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ポナチニブ薬物市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のポナチニブ薬物の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ポナチニブ薬物市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・45mg、15mg

用途別セグメントは次のように区分されます。
・CML、ALL

世界のポナチニブ薬物市場の主要な市場プレーヤーは以下のとおりです。
・ARIAD Pharmaceuticals

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ポナチニブ薬物製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なポナチニブ薬物メーカーの企業概要、2019年～2022年までのポナチニブ薬物の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なポナチニブ薬物メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ポナチニブ薬物の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのポナチニブ薬物の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのポナチニブ薬物市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびポナチニブ薬物の産業チェーンを掲載しています。
・第13、14、15章では、ポナチニブ薬物の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ポナチニブ薬物の概要
- 種類別分析（2017年vs2021年vs2028年）：45mg、15mg
- 用途別分析（2017年vs2021年vs2028年）：CML、ALL
- 世界のポナチニブ薬物市場規模・予測
- 世界のポナチニブ薬物生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- ARIAD Pharmaceuticals
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：45mg、15mg
・用途別分析2017年-2028年：CML、ALL
・ポナチニブ薬物の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ポナチニブ薬物のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ポナチニブ薬物のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ポナチニブ薬物の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ポナチニブ薬物の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Ponatinib Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Ponatinib Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. CML accounting for % of the Ponatinib Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 45mg segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Ponatinib Drugs include ARIAD Pharmaceuticals, , , , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Ponatinib Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
45mg
15mg
Market segment by Application can be divided into
CML
ALL
The key market players for global Ponatinib Drugs market are listed below:
ARIAD Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ponatinib Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Ponatinib Drugs, with price, sales, revenue and global market share of Ponatinib Drugs from 2019 to 2022.
Chapter 3, the Ponatinib Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ponatinib Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Ponatinib Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Ponatinib Drugs.
Chapter 13, 14, and 15, to describe Ponatinib Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Ponatinib Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Ponatinib Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 45mg
1.2.3 15mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Ponatinib Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 CML
1.3.3 ALL
1.4 Global Ponatinib Drugs Market Size & Forecast
1.4.1 Global Ponatinib Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Ponatinib Drugs Sales in Volume (2017-2028)
1.4.3 Global Ponatinib Drugs Price (2017-2028)
1.5 Global Ponatinib Drugs Production Capacity Analysis
1.5.1 Global Ponatinib Drugs Total Production Capacity (2017-2028)
1.5.2 Global Ponatinib Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Ponatinib Drugs Market Drivers
1.6.2 Ponatinib Drugs Market Restraints
1.6.3 Ponatinib Drugs Trends Analysis
2 Manufacturers Profiles
2.1 ARIAD Pharmaceuticals
2.1.1 ARIAD Pharmaceuticals Details
2.1.2 ARIAD Pharmaceuticals Major Business
2.1.3 ARIAD Pharmaceuticals Ponatinib Drugs Product and Services
2.1.4 ARIAD Pharmaceuticals Ponatinib Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Ponatinib Drugs Breakdown Data by Manufacturer
3.1 Global Ponatinib Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Ponatinib Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Ponatinib Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Ponatinib Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Ponatinib Drugs Manufacturer Market Share in 2021
3.5 Global Ponatinib Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Ponatinib Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Ponatinib Drugs Market Size by Region
4.1.1 Global Ponatinib Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Ponatinib Drugs Revenue by Region (2017-2028)
4.2 North America Ponatinib Drugs Revenue (2017-2028)
4.3 Europe Ponatinib Drugs Revenue (2017-2028)
4.4 Asia-Pacific Ponatinib Drugs Revenue (2017-2028)
4.5 South America Ponatinib Drugs Revenue (2017-2028)
4.6 Middle East and Africa Ponatinib Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Ponatinib Drugs Sales in Volume by Type (2017-2028)
5.2 Global Ponatinib Drugs Revenue by Type (2017-2028)
5.3 Global Ponatinib Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Ponatinib Drugs Sales in Volume by Application (2017-2028)
6.2 Global Ponatinib Drugs Revenue by Application (2017-2028)
6.3 Global Ponatinib Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Ponatinib Drugs Sales by Type (2017-2028)
7.2 North America Ponatinib Drugs Sales by Application (2017-2028)
7.3 North America Ponatinib Drugs Market Size by Country
7.3.1 North America Ponatinib Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Ponatinib Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Ponatinib Drugs Sales by Type (2017-2028)
8.2 Europe Ponatinib Drugs Sales by Application (2017-2028)
8.3 Europe Ponatinib Drugs Market Size by Country
8.3.1 Europe Ponatinib Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Ponatinib Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Ponatinib Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Ponatinib Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Ponatinib Drugs Market Size by Region
9.3.1 Asia-Pacific Ponatinib Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Ponatinib Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Ponatinib Drugs Sales by Type (2017-2028)
10.2 South America Ponatinib Drugs Sales by Application (2017-2028)
10.3 South America Ponatinib Drugs Market Size by Country
10.3.1 South America Ponatinib Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Ponatinib Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Ponatinib Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Ponatinib Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Ponatinib Drugs Market Size by Country
11.3.1 Middle East & Africa Ponatinib Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Ponatinib Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Ponatinib Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Ponatinib Drugs
12.3 Ponatinib Drugs Production Process
12.4 Ponatinib Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Ponatinib Drugs Typical Distributors
13.3 Ponatinib Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Ponatinib Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Ponatinib Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. ARIAD Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. ARIAD Pharmaceuticals Major Business
Table 5. ARIAD Pharmaceuticals Ponatinib Drugs Product and Services
Table 6. ARIAD Pharmaceuticals Ponatinib Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Global Ponatinib Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 8. Global Ponatinib Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 9. Market Position of Manufacturers in Ponatinib Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 10. Global Ponatinib Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 11. Head Office and Ponatinib Drugs Production Site of Key Manufacturer
Table 12. Ponatinib Drugs New Entrant and Capacity Expansion Plans
Table 13. Ponatinib Drugs Mergers & Acquisitions in the Past Five Years
Table 14. Global Ponatinib Drugs Sales by Region (2017-2022) & (K Units)
Table 15. Global Ponatinib Drugs Sales by Region (2023-2028) & (K Units)
Table 16. Global Ponatinib Drugs Revenue by Region (2017-2022) & (USD Million)
Table 17. Global Ponatinib Drugs Revenue by Region (2023-2028) & (USD Million)
Table 18. Global Ponatinib Drugs Sales by Type (2017-2022) & (K Units)
Table 19. Global Ponatinib Drugs Sales by Type (2023-2028) & (K Units)
Table 20. Global Ponatinib Drugs Revenue by Type (2017-2022) & (USD Million)
Table 21. Global Ponatinib Drugs Revenue by Type (2023-2028) & (USD Million)
Table 22. Global Ponatinib Drugs Price by Type (2017-2022) & (USD/Unit)
Table 23. Global Ponatinib Drugs Price by Type (2023-2028) & (USD/Unit)
Table 24. Global Ponatinib Drugs Sales by Application (2017-2022) & (K Units)
Table 25. Global Ponatinib Drugs Sales by Application (2023-2028) & (K Units)
Table 26. Global Ponatinib Drugs Revenue by Application (2017-2022) & (USD Million)
Table 27. Global Ponatinib Drugs Revenue by Application (2023-2028) & (USD Million)
Table 28. Global Ponatinib Drugs Price by Application (2017-2022) & (USD/Unit)
Table 29. Global Ponatinib Drugs Price by Application (2023-2028) & (USD/Unit)
Table 30. North America Ponatinib Drugs Sales by Country (2017-2022) & (K Units)
Table 31. North America Ponatinib Drugs Sales by Country (2023-2028) & (K Units)
Table 32. North America Ponatinib Drugs Revenue by Country (2017-2022) & (USD Million)
Table 33. North America Ponatinib Drugs Revenue by Country (2023-2028) & (USD Million)
Table 34. North America Ponatinib Drugs Sales by Type (2017-2022) & (K Units)
Table 35. North America Ponatinib Drugs Sales by Type (2023-2028) & (K Units)
Table 36. North America Ponatinib Drugs Sales by Application (2017-2022) & (K Units)
Table 37. North America Ponatinib Drugs Sales by Application (2023-2028) & (K Units)
Table 38. Europe Ponatinib Drugs Sales by Country (2017-2022) & (K Units)
Table 39. Europe Ponatinib Drugs Sales by Country (2023-2028) & (K Units)
Table 40. Europe Ponatinib Drugs Revenue by Country (2017-2022) & (USD Million)
Table 41. Europe Ponatinib Drugs Revenue by Country (2023-2028) & (USD Million)
Table 42. Europe Ponatinib Drugs Sales by Type (2017-2022) & (K Units)
Table 43. Europe Ponatinib Drugs Sales by Type (2023-2028) & (K Units)
Table 44. Europe Ponatinib Drugs Sales by Application (2017-2022) & (K Units)
Table 45. Europe Ponatinib Drugs Sales by Application (2023-2028) & (K Units)
Table 46. Asia-Pacific Ponatinib Drugs Sales by Region (2017-2022) & (K Units)
Table 47. Asia-Pacific Ponatinib Drugs Sales by Region (2023-2028) & (K Units)
Table 48. Asia-Pacific Ponatinib Drugs Revenue by Region (2017-2022) & (USD Million)
Table 49. Asia-Pacific Ponatinib Drugs Revenue by Region (2023-2028) & (USD Million)
Table 50. Asia-Pacific Ponatinib Drugs Sales by Type (2017-2022) & (K Units)
Table 51. Asia-Pacific Ponatinib Drugs Sales by Type (2023-2028) & (K Units)
Table 52. Asia-Pacific Ponatinib Drugs Sales by Application (2017-2022) & (K Units)
Table 53. Asia-Pacific Ponatinib Drugs Sales by Application (2023-2028) & (K Units)
Table 54. South America Ponatinib Drugs Sales by Country (2017-2022) & (K Units)
Table 55. South America Ponatinib Drugs Sales by Country (2023-2028) & (K Units)
Table 56. South America Ponatinib Drugs Revenue by Country (2017-2022) & (USD Million)
Table 57. South America Ponatinib Drugs Revenue by Country (2023-2028) & (USD Million)
Table 58. South America Ponatinib Drugs Sales by Type (2017-2022) & (K Units)
Table 59. South America Ponatinib Drugs Sales by Type (2023-2028) & (K Units)
Table 60. South America Ponatinib Drugs Sales by Application (2017-2022) & (K Units)
Table 61. South America Ponatinib Drugs Sales by Application (2023-2028) & (K Units)
Table 62. Middle East & Africa Ponatinib Drugs Sales by Region (2017-2022) & (K Units)
Table 63. Middle East & Africa Ponatinib Drugs Sales by Region (2023-2028) & (K Units)
Table 64. Middle East & Africa Ponatinib Drugs Revenue by Region (2017-2022) & (USD Million)
Table 65. Middle East & Africa Ponatinib Drugs Revenue by Region (2023-2028) & (USD Million)
Table 66. Middle East & Africa Ponatinib Drugs Sales by Type (2017-2022) & (K Units)
Table 67. Middle East & Africa Ponatinib Drugs Sales by Type (2023-2028) & (K Units)
Table 68. Middle East & Africa Ponatinib Drugs Sales by Application (2017-2022) & (K Units)
Table 69. Middle East & Africa Ponatinib Drugs Sales by Application (2023-2028) & (K Units)
Table 70. Ponatinib Drugs Raw Material
Table 71. Key Manufacturers of Ponatinib Drugs Raw Materials
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Ponatinib Drugs Typical Distributors
Table 75. Ponatinib Drugs Typical Customers
List of Figures
Figure 1. Ponatinib Drugs Picture
Figure 2. Global Ponatinib Drugs Revenue Market Share by Type in 2021
Figure 3. 45mg
Figure 4. 15mg
Figure 5. Global Ponatinib Drugs Revenue Market Share by Application in 2021
Figure 6. CML
Figure 7. ALL
Figure 8. Global Ponatinib Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Ponatinib Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Ponatinib Drugs Sales (2017-2028) & (K Units)
Figure 11. Global Ponatinib Drugs Price (2017-2028) & (USD/Unit)
Figure 12. Global Ponatinib Drugs Production Capacity (2017-2028) & (K Units)
Figure 13. Global Ponatinib Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Ponatinib Drugs Market Drivers
Figure 15. Ponatinib Drugs Market Restraints
Figure 16. Ponatinib Drugs Market Trends
Figure 17. Global Ponatinib Drugs Sales Market Share by Manufacturer in 2021
Figure 18. Global Ponatinib Drugs Revenue Market Share by Manufacturer in 2021
Figure 19. Ponatinib Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Ponatinib Drugs Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Ponatinib Drugs Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Ponatinib Drugs Sales Market Share by Region (2017-2028)
Figure 23. Global Ponatinib Drugs Revenue Market Share by Region (2017-2028)
Figure 24. North America Ponatinib Drugs Revenue (2017-2028) & (USD Million)
Figure 25. Europe Ponatinib Drugs Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Ponatinib Drugs Revenue (2017-2028) & (USD Million)
Figure 27. South America Ponatinib Drugs Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Ponatinib Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Global Ponatinib Drugs Sales Market Share by Type (2017-2028)
Figure 30. Global Ponatinib Drugs Revenue Market Share by Type (2017-2028)
Figure 31. Global Ponatinib Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 32. Global Ponatinib Drugs Sales Market Share by Application (2017-2028)
Figure 33. Global Ponatinib Drugs Revenue Market Share by Application (2017-2028)
Figure 34. Global Ponatinib Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 35. North America Ponatinib Drugs Sales Market Share by Type (2017-2028)
Figure 36. North America Ponatinib Drugs Sales Market Share by Application (2017-2028)
Figure 37. North America Ponatinib Drugs Sales Market Share by Country (2017-2028)
Figure 38. North America Ponatinib Drugs Revenue Market Share by Country (2017-2028)
Figure 39. United States Ponatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Ponatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Ponatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Ponatinib Drugs Sales Market Share by Type (2017-2028)
Figure 43. Europe Ponatinib Drugs Sales Market Share by Application (2017-2028)
Figure 44. Europe Ponatinib Drugs Sales Market Share by Country (2017-2028)
Figure 45. Europe Ponatinib Drugs Revenue Market Share by Country (2017-2028)
Figure 46. Germany Ponatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Ponatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Ponatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Ponatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Ponatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Ponatinib Drugs Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Ponatinib Drugs Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Ponatinib Drugs Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Ponatinib Drugs Revenue Market Share by Region (2017-2028)
Figure 55. China Ponatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Ponatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Ponatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Ponatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Ponatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Ponatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Ponatinib Drugs Sales Market Share by Type (2017-2028)
Figure 62. South America Ponatinib Drugs Sales Market Share by Application (2017-2028)
Figure 63. South America Ponatinib Drugs Sales Market Share by Country (2017-2028)
Figure 64. South America Ponatinib Drugs Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Ponatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Ponatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Ponatinib Drugs Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Ponatinib Drugs Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Ponatinib Drugs Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Ponatinib Drugs Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Ponatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Ponatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Ponatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Ponatinib Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Ponatinib Drugs in 2021
Figure 76. Manufacturing Process Analysis of Ponatinib Drugs
Figure 77. Ponatinib Drugs Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ポナチニブ薬のグローバル市場展望 2023年-2029年：45mg、15mg
  • 世界のポナチニブ市場2022年：市場規模予測（～2028年）
  • ポナチニブのグローバル市場展望 2023年-2029年：45mg、15mg
  • ポナチニブHClのグローバル市場展望 2023年-2029年：研究用ポナチニブHCl、診断用ポナチニブHCl
  • 世界のオシメルチニブ医薬品市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19557 )"世界のポナチニブ薬物市場2022年：市場規模予測（～2028年）" (英文：Global Ponatinib Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。